NEW YORK (Reuters Health) – For patients with diabetes and hypertension, an antihypertensive regimen combining an ACE inhibitor with a calcium channel blocker provides better protection against cardiovascular…
NEW YORK (Reuters Health) – For patients with severe acute exacerbation of chronic obstructive pulmonary disease (COPD), trimethoprim-sulfamethoxazole was just as effective and safe as ciprofloxacin in a…
NEW YORK (Reuters Health) – Despite its widespread use, there is no conclusive evidence that oxygen therapy benefits patients with acute myocardial infarction (AMI), according to a paper…
NEW YORK (Reuters Health) – Intravenous magnesium sulfate infusions may not help patients with acute aneurysmal subarachnoid hemorrhage, according to a study published in the August issue of…
NEW YORK (Reuters Health) – By evaluating risk factors for thromboembolism, physicians can reduce the number of computed tomography (CT) angiograms they order for patients with suspected pulmonary…
NEW YORK (Reuters Health) – Enterally administered probiotic treatment with Lactobacillus rhamnosus GG can cut the rate of ventilator-associated pneumonia (VAP) in high-risk patients, according to pilot study…
NEW YORK (Reuters Health) – Nine times out of 10, patients admitted to a U.S. hospital for acute exacerbation of chronic obstructive pulmonary disease (COPD) are treated initially…
NEW YORK (Reuters Health) – The novel antiarrhythmic agent vernakalant is a safe and effective agent for pharmacologic conversion of recent-onset atrial fibrillation (AF) in hemodynamically stable patients,…
NEW YORK (Reuters Health) – Inhaled anticholinergics may increase the risk of community-acquired pneumonia in asthma patients, results of a Spanish case-control study suggest. The findings, published online…
NEW YORK (Reuters Health) – More than half of elderly patients who come out of the hospital after pneumonia either die within a year or get readmitted for…